Category Archives: Events

Innovation Drops Down NICE’s Value Agenda

Innovation as a consideration of value-based pricing decisions will be conspicuous by its absence in future NICE decisions. Omar Ali, a UK formulary development pharmacist and consultant to NICE, speaking at eyeforpharma’s Barcelona 2014 conference on Wednesday, explained that the UK price watchdog will prioritize considerations of wider societal benefit and unmet need as it […]
Also posted in Europe, pricing | Tagged , , , , , | Leave a comment

Drug Discovery CRO Sector to Thrive in Europe

The European pharmaceutical industry is changing its approach to R&D and is increasingly relying on outsourcing for drug discovery, writes Faiz Kermani. The European pharmaceutical industry accounts for nearly 40% of the global industry’s R&D investment. Although  companies are responding to current pressures by closing R&D sites, they still need to support their ongoing drug-development projects […]
Also posted in Europe, Global, Guest Blog, R&D | Tagged , , , | Leave a comment

Europe: EFPIA Campaign Calls for Integrated Life Sciences Strategy

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has launched a social media campaign calling for an integrated life sciences  strategy for the EU. The #HealthyEU Health and Growth campaign will outline the opportunities and threats faced by patients and the healthcare sector today, and provide evidence and facts to inform healthcare debates in the run […]
Also posted in E-Media, Europe, Global, multimedia, Regulatory, social media, Strategy | Tagged , , , , , | Leave a comment

ACA Rollout Raises Ante for Patient Access and Assistance

By Michael Christel. Amid the looming March 31 deadline for remaining uninsured and underinsured Americans to purchase health insurance mandated by the Affordable Care Act (6 million newly Medicaid-eligible individuals are expected to enroll), pharmaceutical manufacturers and other key players in this space are emphasizing the importance of enhancing access to medications for the now […]
Also posted in Regulatory | Tagged , , , , | Leave a comment

Swedish Firm Honored for Rare Disease Treatments

Swedish Orphan Biovitrum AB (Sobi) was last night presented with a EURORDIS Award for its commercial and development portfolio in the field of rare diseases. The award also recognized the company’s track record on access to drugs and its collaboration with patient organizations. EURORDIS is Europe’s largest patient organization in rare diseases. Its CEO, Yann […]
Also posted in Europe, Global, Orphan Drugs | Tagged , , , | Leave a comment
  • Categories

  • Meta